Heidi Hagen

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Gabriela Morales-Rivera, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Heidi Hagen

Form 4 holding Director

Vericel Corp

Security class
Restricted Stock Unit
Shares / value
3,200
Estimated value
$57,600
Report date
01 May 2024
Price
$18.00
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ZIOPHARM ONCOLOGY INC

Security class
Common Stock
Shares / value
145,889
Estimated value
$20,468
Report date
02 Sep 2021
Price
$0.1403
Ownership
Direct
Form 4 holding Director

Obsidian Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
37,653
Estimated value
Report date
03 Aug 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Vericel Corp

Security class
Stock Option (Right to Buy)
Shares / value
8,000
Estimated value
Report date
29 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Vericel Corp

Security class
Restricted Stock Unit
Shares / value
3,200
Estimated value
Report date
29 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Heidi Hagen

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .